Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling with topical basic fibroblast growth factor for stretch marks
IRCT20220924056033N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of trafermin in Striae atrophicae (SA) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Clinical improvement of striae. Started Oct 2022; status: completed.
02
Drugs
trafermin
03
Conditions
Striae atrophicae (SA)
Beyond the preview
Go deeper on IRCT20220924056033N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220924056033N1.